LONDON–(BUSINESS WIRE)–The global life science software market is expected to register an incremental growth of USD 2.55 billion, witnessing a CAGR of over 7% during 2020-2024, according to the latest market research analysis by Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the life science software market in optimistic, probable, and pessimistic forecast scenarios.
Get detailed insights on COVID-19 pandemic Crisis and Recovery analysis of the Life Science Software market. Download free report sample
Amid the COVID-19 Crisis, the Revaluated and Updated Life Science Software Market Report Says:
- The life science software market will witness a Positive and Superior impact during the forecast period owing to the extensive rise of COVID-19 pandemic.
- Due to the extensive spread of the virus across the globe, the Information Technology industry is anticipated to have Mixed and Direct impact
- Furthermore, as per Technavio’s pandemic-focused research